Raphy Blum, Committee Chair

Raphel (Raphy) Blum, Committee Chair
General Manager of AbbVie in Israel since March 2017

He came back to Israel after 14 years in the US. He has extensive experience in the pharmaceutical business, bringing significant commercial experience across a broad range of Therapy Areas in a Country organization (Israel), Regions (US, EU & Asia) as well as Global pharmaceutical markets. This includes development of the full brand life cycle, new market development, brand introductions, in-line product management, brand repositioning, and market exit.

Raphy also co-led the integration of Wyeth Oncology into the Pfizer Oncology Business unit globally.

Committee Members:

  • Yael Ravhon, CEO, Abbott Medical Laboratories

  • Miron Livneh, CEO, Pfizer Pharmaceuticals Israel

  • Mati Gil, Head of Government Affairs Corporate & International Markets at Teva Pharmaceuticals


Back to top